{"transactions":[{"id":1209815,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T08:12:50.000Z","date":"2025-03-10","kind":"other","planned":false,"acquired":false,"shares":350000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were transferred to RS Group ApS pursuant to a settlement agreement terminating the action entitled RS Group ApS v. GWRS Holdings LLC et al. (Superior Court of Los Angeles County, CA, Case No. 22STCV26335)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were transferred to RS Group ApS pursuant to a settlement agreement terminating the action entitled RS Group ApS v. GWRS Holdings LLC et al. (Superior Court of Los Angeles County, CA, Case No. 22STCV26335)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS)."}],"balance_after":3353878,"source":{"system":"sec-edgar","filing":"0001214659-25-004233","document":"marketforms-68711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465925004233/marketforms-68711.xml","form_type":"4"}},{"id":1245394,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82811,"kind":"person","name":"Fuentes Nathen","position":1,"cik":"0002005072","reported_name":"Fuentes Nathen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase shares of common stock","published_at":"2025-02-25T18:29:46.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in eight equal quarterly installments beginning on January 6, 2025."}],"balance_after":250000,"derivative":{"exercise_price":0.71,"expiration_date":"2035-01-21","underlying":"Common stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001731122-25-000293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225000293/ownership.xml","form_type":"4"}},{"id":1246970,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82835,"kind":"person","name":"van Tilburg Maurice","position":1,"cik":"0002043498","reported_name":"van Tilburg Maurice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2025-02-25T13:33:34.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in five equal annual installments beginning on December 30, 2025."}],"balance_after":1000000,"derivative":{"exercise_price":0.72,"expiration_date":"2035-01-21","underlying":"Common stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001731122-25-000295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2043498/000173112225000295/ownership.xml","form_type":"4"}},{"id":1246969,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82835,"kind":"person","name":"van Tilburg Maurice","position":1,"cik":"0002043498","reported_name":"van Tilburg Maurice","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-25T13:33:34.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in five equal annual installments beginning on December 30, 2025."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001731122-25-000295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043498/000173112225000295/ownership.xml","form_type":"4"}},{"id":1373129,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":86261,"kind":"person","name":"Collins Mark Anthony","position":1,"cik":"0002043093","reported_name":"Collins Mark Anthony","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-07T12:18:54.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":120968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120968,"derivative":{"exercise_price":0.62,"exercise_date":"2025-10-14","expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":120968},"source":{"system":"sec-edgar","filing":"0001731122-24-001740","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2043093/000173112224001740/ownership.xml","form_type":"4"}},{"id":1374028,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":36782,"kind":"person","name":"Calder Douglas W","position":1,"cik":"0001510445","reported_name":"Calder Douglas W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-06T21:54:39.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":120968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120968,"derivative":{"exercise_price":0.62,"exercise_date":"2025-10-14","expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":120968},"source":{"system":"sec-edgar","filing":"0001731122-24-001729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1510445/000173112224001729/ownership.xml","form_type":"4"}},{"id":1374050,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":26799,"kind":"person","name":"MCNULTY JAMES A","position":1,"cik":"0001275857","reported_name":"MCNULTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-06T20:25:02.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":120968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":120968,"derivative":{"exercise_price":0.62,"exercise_date":"2025-10-14","expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":120968},"source":{"system":"sec-edgar","filing":"0001731122-24-001719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275857/000173112224001719/ownership.xml","form_type":"4"}},{"id":1374379,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Option to purchase shares of common stock","published_at":"2024-11-06T16:34:21.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":58500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests upon the termination of the Consulting Agreement effective November 4, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date."}],"balance_after":58500,"derivative":{"exercise_price":0.62,"expiration_date":"2034-11-04","underlying":"Common stock","underlying_shares":58500},"source":{"system":"sec-edgar","filing":"0001731122-24-001725","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000173112224001725/ownership.xml","form_type":"4"}},{"id":1380167,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":86496,"kind":"person","name":"Weinstein David Hershel","position":1,"cik":"0002042640","reported_name":"Weinstein David Hershel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to purchase shares of common stock","published_at":"2024-10-29T14:36:23.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":1600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in eight equal quarterly installments beginning on January 1, 2025."}],"balance_after":1600000,"derivative":{"exercise_price":0.55,"expiration_date":"2034-10-14","underlying":"Common stock","underlying_shares":1600000},"source":{"system":"sec-edgar","filing":"0001731122-24-001669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042640/000173112224001669/ownership.xml","form_type":"4"}},{"id":1380166,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":86496,"kind":"person","name":"Weinstein David Hershel","position":1,"cik":"0002042640","reported_name":"Weinstein David Hershel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-10-29T14:36:23.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001731122-24-001669","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042640/000173112224001669/ownership.xml","form_type":"4"}},{"id":1381943,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-10-24T08:56:28.000Z","date":"2024-07-29","kind":"sale","planned":false,"acquired":false,"shares":1114,"price":1.3,"value":1448.2,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.30 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":840319,"source":{"system":"sec-edgar","filing":"0001214659-24-017879","document":"marketforms-67178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924017879/marketforms-67178.xml","form_type":"4"}},{"id":1422161,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":87967,"kind":"person","name":"Miller Avram","position":1,"cik":"0002000641","reported_name":"Miller Avram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Shares of Common Stock","published_at":"2024-08-27T16:05:56.000Z","date":"2024-08-23","kind":"grant","planned":false,"acquired":true,"shares":978261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant."}],"balance_after":978261,"derivative":{"exercise_price":0.69,"expiration_date":"2034-08-23","underlying":"Common Stock","underlying_shares":978261},"source":{"system":"sec-edgar","filing":"0001731122-24-001325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2000641/000173112224001325/ownership.xml","form_type":"4"}},{"id":1422160,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":87967,"kind":"person","name":"Miller Avram","position":1,"cik":"0002000641","reported_name":"Miller Avram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T16:05:56.000Z","date":"2024-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":833333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock."}],"balance_after":166667,"source":{"system":"sec-edgar","filing":"0001731122-24-001325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000641/000173112224001325/ownership.xml","form_type":"4"}},{"id":1431577,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":88257,"kind":"person","name":"Brink Karen","position":1,"cik":"0002012444","reported_name":"Brink Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-16T16:43:13.000Z","date":"2024-08-12","kind":"other","planned":false,"acquired":true,"shares":2000000,"ownership":{"direct":false,"nature":"By Yalla Yalla Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":25372969,"source":{"system":"sec-edgar","filing":"0001213900-24-070297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012444/000121390024070297/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-13"}},{"id":1434994,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":88257,"kind":"person","name":"Brink Karen","position":1,"cik":"0002012444","reported_name":"Brink Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T16:01:25.000Z","date":"2024-08-12","kind":"other","planned":false,"acquired":false,"shares":2000000,"ownership":{"direct":false,"nature":"By Yalla Yalla Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":23372969,"source":{"system":"sec-edgar","filing":"0001213900-24-068233","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012444/000121390024068233/ownership.xml","form_type":"4"}},{"id":1451222,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-19T17:44:16.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":16362,"price":1.46,"value":23888.52,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.45 to $1.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":841433,"source":{"system":"sec-edgar","filing":"0001214659-24-012745","document":"marketforms-66622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012745/marketforms-66622.xml","form_type":"4"}},{"id":1452646,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T16:32:08.000Z","date":"2024-07-15","kind":"sale","planned":false,"acquired":false,"shares":21954,"price":1.41,"value":30955.14,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.40 to $1.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":875795,"source":{"system":"sec-edgar","filing":"0001214659-24-012571","document":"marketforms-66579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012571/marketforms-66579.xml","form_type":"4"}},{"id":1454627,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-15T08:46:46.000Z","date":"2024-07-11","kind":"sale","planned":false,"acquired":false,"shares":14896,"price":1.51,"value":22492.96,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":897749,"source":{"system":"sec-edgar","filing":"0001214659-24-012367","document":"marketforms-66563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012367/marketforms-66563.xml","form_type":"4"}},{"id":1454626,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-15T08:46:46.000Z","date":"2024-07-10","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":1.51,"value":113250.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":894645,"source":{"system":"sec-edgar","filing":"0001214659-24-012367","document":"marketforms-66563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012367/marketforms-66563.xml","form_type":"4"}},{"id":1454625,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-15T08:46:46.000Z","date":"2024-07-09","kind":"sale","planned":false,"acquired":false,"shares":4630,"price":1.53,"value":7083.9,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.52 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is sole manager of Weird Science LLC."}],"balance_after":969645,"source":{"system":"sec-edgar","filing":"0001214659-24-012367","document":"marketforms-66563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012367/marketforms-66563.xml","form_type":"4"}},{"id":1458346,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T16:50:03.000Z","date":"2024-07-05","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":1.55,"value":93000.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":974275,"source":{"system":"sec-edgar","filing":"0001214659-24-012082","document":"marketforms-66527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012082/marketforms-66527.xml","form_type":"4"}},{"id":1458345,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T16:50:03.000Z","date":"2024-07-03","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":1.51,"value":75500.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1034275,"source":{"system":"sec-edgar","filing":"0001214659-24-012082","document":"marketforms-66527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924012082/marketforms-66527.xml","form_type":"4"}},{"id":1460130,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T19:04:46.000Z","date":"2024-07-02","kind":"sale","planned":false,"acquired":false,"shares":34553,"price":1.54,"value":53211.62,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1084275,"source":{"system":"sec-edgar","filing":"0001214659-24-011987","document":"marketforms-66503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011987/marketforms-66503.xml","form_type":"4"}},{"id":1460129,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T19:04:46.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":1.56,"value":93600.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1118828,"source":{"system":"sec-edgar","filing":"0001214659-24-011987","document":"marketforms-66503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011987/marketforms-66503.xml","form_type":"4"}},{"id":1460531,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":88257,"kind":"person","name":"Brink Karen","position":1,"cik":"0002012444","reported_name":"Brink Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-03T16:05:08.000Z","date":"2024-06-06","kind":"other","planned":false,"acquired":false,"shares":1853517,"ownership":{"direct":false,"nature":"By Yalla Yalla Ltd."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"shares","element":"transactionShares","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. (\"Yalla Yalla\") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein."}],"balance_after":25372969,"source":{"system":"sec-edgar","filing":"0001213900-24-059029","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012444/000121390024059029/ownership.xml","form_type":"4"}},{"id":1466079,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":87967,"kind":"person","name":"Miller Avram","position":1,"cik":"0002000641","reported_name":"Miller Avram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-07-01T08:40:27.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":18634,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18634,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":18634},"source":{"system":"sec-edgar","filing":"0001731122-24-001048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000641/000173112224001048/ownership.xml","form_type":"4"}},{"id":1467978,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:55:36.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":48137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48137,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":48137},"source":{"system":"sec-edgar","filing":"0001731122-24-001037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001037/ownership.xml","form_type":"4"}},{"id":1468105,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":20830,"kind":"person","name":"Brosgart Carol L","position":1,"cik":"0001614724","reported_name":"Brosgart Carol L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:54:45.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":42857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42857,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":42857},"source":{"system":"sec-edgar","filing":"0001731122-24-001035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614724/000173112224001035/ownership.xml","form_type":"4"}},{"id":1467976,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89466,"kind":"person","name":"McNicol Jayne","position":1,"cik":"0001866827","reported_name":"McNicol Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:53:57.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":46584,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46584,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":46584},"source":{"system":"sec-edgar","filing":"0001731122-24-001033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001033/ownership.xml","form_type":"4"}},{"id":1468001,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:53:05.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":48137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48137,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":48137},"source":{"system":"sec-edgar","filing":"0001731122-24-001031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112224001031/ownership.xml","form_type":"4"}},{"id":1467977,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T22:49:06.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":62112,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"balance_after":62.112,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":62112},"source":{"system":"sec-edgar","filing":"0001731122-24-001029","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224001029/ownership.xml","form_type":"4"}},{"id":1468171,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-27T19:37:43.000Z","date":"2024-06-27","kind":"sale","planned":false,"acquired":false,"shares":14671,"price":1.5,"value":22006.5,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1178828,"source":{"system":"sec-edgar","filing":"0001214659-24-011566","document":"marketforms-66440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011566/marketforms-66440.xml","form_type":"4"}},{"id":1468170,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-27T19:37:43.000Z","date":"2024-06-26","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":1.57,"value":78500.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1193499,"source":{"system":"sec-edgar","filing":"0001214659-24-011566","document":"marketforms-66440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011566/marketforms-66440.xml","form_type":"4"}},{"id":1468169,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-27T19:37:43.000Z","date":"2024-06-25","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":1.58,"value":31600.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1243499,"source":{"system":"sec-edgar","filing":"0001214659-24-011566","document":"marketforms-66440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011566/marketforms-66440.xml","form_type":"4"}},{"id":1468439,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89493,"kind":"person","name":"Hendriks Ruud","position":1,"cik":"0001996999","reported_name":"Hendriks Ruud","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-06-27T18:56:24.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":18634,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18634,"derivative":{"exercise_price":1.61,"exercise_date":"2024-06-25","expiration_date":"2034-06-25","underlying":"Common stock","underlying_shares":18634},"source":{"system":"sec-edgar","filing":"0001731122-24-001039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1996999/000173112224001039/ownership.xml","form_type":"4"}},{"id":1475438,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T18:38:41.000Z","date":"2024-06-14","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":1.58,"value":79000.0,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1263499,"source":{"system":"sec-edgar","filing":"0001214659-24-011150","document":"marketforms-66393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465924011150/marketforms-66393.xml","form_type":"4"}},{"id":1497520,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89466,"kind":"person","name":"McNicol Jayne","position":1,"cik":"0001866827","reported_name":"McNicol Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-05-31T01:35:49.000Z","date":"2024-05-26","kind":"grant","planned":false,"acquired":true,"shares":52817,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52817,"derivative":{"exercise_price":1.42,"exercise_date":"2025-05-26","expiration_date":"2034-05-26","underlying":"Common Stock","underlying_shares":52817},"source":{"system":"sec-edgar","filing":"0001731122-24-000898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000898/ownership.xml","form_type":"4"}},{"id":1567618,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2024-03-19T15:18:06.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":28196,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28196,"derivative":{"exercise_price":2.66,"exercise_date":"2025-03-06","expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":28196},"source":{"system":"sec-edgar","filing":"0001731122-24-000455","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000455/ownership.xml","form_type":"4"}},{"id":1579063,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Option to purchase shares of common stock","published_at":"2024-03-13T15:50:48.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests upon the termination of the Consulting Agreement effective March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date."}],"balance_after":10000,"derivative":{"exercise_price":2.98,"expiration_date":"2034-03-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001731122-24-000425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000173112224000425/ownership.xml","form_type":"4"}},{"id":1612254,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":20830,"kind":"person","name":"Brosgart Carol L","position":1,"cik":"0001614724","reported_name":"Brosgart Carol L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-02-28T20:20:32.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":23810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23810,"derivative":{"exercise_price":3.15,"exercise_date":"2024-12-27","expiration_date":"2033-12-27","underlying":"Common stock","underlying_shares":23810},"source":{"system":"sec-edgar","filing":"0001731122-24-000322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614724/000173112224000322/ownership.xml","form_type":"4"}},{"id":1624798,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-02-22T21:35:47.000Z","date":"2024-02-20","kind":"other","planned":false,"acquired":false,"shares":471699,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"balance_after":471698,"derivative":{"exercise_price":0.53,"exercise_date":"2023-06-26","expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":471699},"source":{"system":"sec-edgar","filing":"0001731122-24-000292","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000292/ownership.xml","form_type":"4"}},{"id":1624797,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T21:35:47.000Z","date":"2024-02-20","kind":"other","planned":false,"acquired":true,"shares":471699,"price":0.53,"value":250000.47,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"balance_after":13605297,"source":{"system":"sec-edgar","filing":"0001731122-24-000292","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000292/ownership.xml","form_type":"4"}},{"id":1632747,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94116,"kind":"person","name":"Abildgaard Ole","position":1,"cik":"0001994976","reported_name":"Abildgaard Ole","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-02-20T21:20:42.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":343619,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Preferred Stock is convertible into common stock on a 1-for-10 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Preferred Stock is perpetual and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2023-08-01","underlying":"Common Stock","underlying_shares":3436190},"source":{"system":"sec-edgar","filing":"0001213900-24-015328","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121390024015328/ownership.xml","form_type":"4"}},{"id":1632746,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94116,"kind":"person","name":"Abildgaard Ole","position":1,"cik":"0001994976","reported_name":"Abildgaard Ole","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:20:42.000Z","date":"2023-08-22","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer."}],"balance_after":6898482,"source":{"system":"sec-edgar","filing":"0001213900-24-015328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121390024015328/ownership.xml","form_type":"4"}},{"id":1632745,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94116,"kind":"person","name":"Abildgaard Ole","position":1,"cik":"0001994976","reported_name":"Abildgaard Ole","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:20:42.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer."}],"balance_after":7398482,"source":{"system":"sec-edgar","filing":"0001213900-24-015328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121390024015328/ownership.xml","form_type":"4"}},{"id":1632744,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94116,"kind":"person","name":"Abildgaard Ole","position":1,"cik":"0001994976","reported_name":"Abildgaard Ole","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-20T21:20:42.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":3436190,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series A Convertible Preferred Stock (\"Preferred Stock\") automatically converted into shares of common stock on a 1-for-10 basis pursuant to their terms upon the closing of the issuer's acquisition of GEDi Cube Int. Ltd. pursuant to that certain Stock Purchase Agreement, dated September 28, 2023, by and among the issuer, GEDi Cube Intl Ltd., the other sellers party thereto, and Yalla Yalla Ltd., in its capacity as the representative of the sellers."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reported securities are held directly by Paseco ApS. Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Mr. Abildgaard also directly owns 5,000 shares of the common stock of the issuer."}],"balance_after":7898482,"source":{"system":"sec-edgar","filing":"0001213900-24-015328","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121390024015328/ownership.xml","form_type":"4"}},{"id":1637654,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":40000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637653,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637652,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":65000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637651,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":0,"derivative":{"exercise_price":8.4,"exercise_date":"2023-04-18","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637650,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":65000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637649,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94210,"kind":"person","name":"Binette Francois","position":1,"cik":"0001940686","reported_name":"Binette Francois","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO and Executive VP for R&D"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:44:03.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"60% of the option vested on January 22, 2023 and 40% on July 22, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001731122-24-000268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000268/ownership.xml","form_type":"4"}},{"id":1637648,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":80000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637647,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.15,"expiration_date":"2032-10-18","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637646,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":75000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637645,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested on January 22, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.38,"expiration_date":"2032-07-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637644,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":60000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637643,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in three equal installments on October 26, 2021, October 26, 2022 and October 26, 2023."}],"balance_after":0,"derivative":{"exercise_price":8.58,"expiration_date":"2031-10-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637642,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":60000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637641,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94209,"kind":"person","name":"Puche Luisa","position":1,"cik":"0001768468","reported_name":"Puche Luisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:13:55.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in three equal installments on January 7, 2019, January 7, 2020 and January 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001731122-24-000264","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000264/ownership.xml","form_type":"4"}},{"id":1637640,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":350000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025."}],"balance_after":350000,"derivative":{"exercise_price":1.92,"expiration_date":"2032-08-25","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637639,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":350000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the option vested on August 25, 2023. The remainder of the option shall vest in two equal installments on August 25, 2024 and August 25, 2025."}],"balance_after":0,"derivative":{"exercise_price":2.54,"expiration_date":"2032-08-25","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637638,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024."}],"balance_after":2000000,"derivative":{"exercise_price":1.92,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637637,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in two equal installments on July 1, 2022 and July 1, 2023. The remainder of the option vests on July 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":4.57,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637636,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":450000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637635,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":0,"derivative":{"exercise_price":8,"exercise_date":"2021-06-11","expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637634,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":300000,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2028-11-21","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637633,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":0,"derivative":{"exercise_price":6.5,"exercise_date":"2018-11-21","expiration_date":"2028-11-21","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637632,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":5226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":5226,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2028-09-19","underlying":"Common Stock","underlying_shares":5226},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637631,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5226,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":0,"derivative":{"exercise_price":5.74,"exercise_date":"2019-02-28","expiration_date":"2028-09-19","underlying":"Common Stock","underlying_shares":5226},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637630,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":7563,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."}],"balance_after":7563,"derivative":{"exercise_price":1.92,"exercise_date":"2024-02-13","expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":7563},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1637629,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":94208,"kind":"person","name":"Dybul Mark","position":1,"cik":"0001734805","reported_name":"Dybul Mark","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2024-02-16T14:06:47.000Z","date":"2024-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7563,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a stock option repricing (the \"Option Repricing\") effective on February 13, 2024 (the \"Repricing Date\"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in three equal installments on February 28, 2019, February 28, 2020 and February 28, 2021."}],"balance_after":0,"derivative":{"exercise_price":5.95,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":7563},"source":{"system":"sec-edgar","filing":"0001731122-24-000263","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000263/ownership.xml","form_type":"4"}},{"id":1640649,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-02-15T23:38:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":false,"shares":70126,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Preferred Stock is convertible into Common Stock on a one-for-ten basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock is perpetual and has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2023-08-01","underlying":"Common Stock","underlying_shares":701260},"source":{"system":"sec-edgar","filing":"0001731122-24-000254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000254/ownership.xml","form_type":"4"}},{"id":1640648,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-15T23:38:55.000Z","date":"2024-02-13","kind":"exercise","planned":false,"acquired":true,"shares":701260,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series A Convertible Preferred Stock (\"Preferred Stock\") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share."}],"balance_after":13133598,"source":{"system":"sec-edgar","filing":"0001731122-24-000254","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112224000254/ownership.xml","form_type":"4"}},{"id":1661093,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":16003,"kind":"person","name":"Alton Gregg H","position":1,"cik":"0001334682","reported_name":"Alton Gregg H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2024-02-02T17:14:37.000Z","date":"2023-12-27","kind":"grant","planned":false,"acquired":true,"shares":23810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23810,"derivative":{"exercise_price":3.15,"exercise_date":"2024-12-27","expiration_date":"2033-12-27","underlying":"Common stock","underlying_shares":23810},"source":{"system":"sec-edgar","filing":"0001731122-24-000185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334682/000173112224000185/ownership.xml","form_type":"4"}},{"id":1742566,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":87967,"kind":"person","name":"Miller Avram","position":1,"cik":"0002000641","reported_name":"Miller Avram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2023-11-14T09:56:35.000Z","date":"2023-10-23","kind":"grant","planned":false,"acquired":true,"shares":27147,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27147,"derivative":{"exercise_price":2.76,"exercise_date":"2024-10-11","expiration_date":"2033-10-11","underlying":"Common stock","underlying_shares":27147},"source":{"system":"sec-edgar","filing":"0001731122-23-002098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2000641/000173112223002098/ownership.xml","form_type":"4"}},{"id":1742565,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":87967,"kind":"person","name":"Miller Avram","position":1,"cik":"0002000641","reported_name":"Miller Avram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T09:56:35.000Z","date":"2023-10-23","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On October 11, 2023, the Reporting Person entered into an Advisory Agreement, pursuant to which the Issuer agreed to issue Mr. Miller 1,000,000 shares of restricted stock, 166,667 of which will vest in 2024, 444,444 will vest in 2025, and 388,889 will vest in 2026, subject to Mr. Miller's continued service through each applicable vesting date."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001731122-23-002098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2000641/000173112223002098/ownership.xml","form_type":"4"}},{"id":1754510,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89493,"kind":"person","name":"Hendriks Ruud","position":1,"cik":"0001996999","reported_name":"Hendriks Ruud","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2023-10-27T10:53:43.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":16129,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16129,"derivative":{"exercise_price":4.65,"exercise_date":"2024-10-04","expiration_date":"2033-10-04","underlying":"Common stock","underlying_shares":16129},"source":{"system":"sec-edgar","filing":"0001731122-23-001972","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1996999/000173112223001972/ownership.xml","form_type":"4"}},{"id":1755141,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":31542,"kind":"person","name":"Boeren Leni","position":1,"cik":"0001998190","reported_name":"Boeren Leni","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2023-10-25T14:56:02.000Z","date":"2023-10-04","kind":"grant","planned":false,"acquired":true,"shares":16129,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16129,"derivative":{"exercise_price":4.65,"exercise_date":"2024-10-04","expiration_date":"2033-10-04","underlying":"Common stock","underlying_shares":16129},"source":{"system":"sec-edgar","filing":"0001731122-23-001947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001947/ownership.xml","form_type":"4"}},{"id":1757381,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":108879,"kind":"person","name":"Gronfeldt-Sorensen Henrik","position":1,"cik":"0001720024","reported_name":"Gronfeldt-Sorensen Henrik","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase shares of common stock","published_at":"2023-10-19T17:09:26.000Z","date":"2023-10-09","kind":"grant","planned":false,"acquired":true,"shares":17242,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17242,"derivative":{"exercise_price":4.35,"exercise_date":"2024-10-09","expiration_date":"2033-10-09","underlying":"Common stock","underlying_shares":17242},"source":{"system":"sec-edgar","filing":"0001731122-23-001919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001919/ownership.xml","form_type":"4"}},{"id":1782722,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-09-12T10:08:23.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":350630,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Granted to the Reporting Person as warrant coverage in connection with the Preferred Stock reported above."}],"balance_after":350630,"derivative":{"exercise_price":0.65,"exercise_date":"2023-08-01","expiration_date":"2028-08-01","underlying":"Common Stock","underlying_shares":350630},"source":{"system":"sec-edgar","filing":"0001731122-23-001669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001669/ownership.xml","form_type":"4"}},{"id":1782721,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2023-09-12T10:08:23.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":70126,"price":7.13,"value":499998.38,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock (\"Preferred Stock\") is convertible into Common Stock on a one-for-ten basis"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Preferred Stock is perpetual and has no expiration date."}],"balance_after":70126,"derivative":{"exercise_price":0,"exercise_date":"2023-08-01","underlying":"Common Stock","underlying_shares":701260},"source":{"system":"sec-edgar","filing":"0001731122-23-001669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001669/ownership.xml","form_type":"4"}},{"id":1818968,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Option to purchase shares of Common Stock","published_at":"2023-08-01T23:47:29.000Z","date":"2023-07-30","kind":"grant","planned":false,"acquired":true,"shares":131579,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":131579,"derivative":{"exercise_price":0.57,"exercise_date":"2024-07-30","expiration_date":"2033-07-30","underlying":"Common Stock","underlying_shares":131579},"source":{"system":"sec-edgar","filing":"0001731122-23-001334","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001334/ownership.xml","form_type":"4"}},{"id":1843291,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-06-28T00:29:51.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":943397,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I."}],"balance_after":943397,"derivative":{"exercise_price":0.53,"exercise_date":"2023-06-26","expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":943397},"source":{"system":"sec-edgar","filing":"0001731122-23-001221","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001221/ownership.xml","form_type":"4"}},{"id":1843290,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-28T00:29:51.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":1886794,"price":0.53,"value":1000000.82,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"balance_after":12432338,"source":{"system":"sec-edgar","filing":"0001731122-23-001221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001221/ownership.xml","form_type":"4"}},{"id":1855557,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89466,"kind":"person","name":"McNicol Jayne","position":1,"cik":"0001866827","reported_name":"McNicol Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-06-15T01:26:51.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":79787,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79787,"derivative":{"exercise_price":0.94,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":79787},"source":{"system":"sec-edgar","filing":"0001731122-23-001136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001136/ownership.xml","form_type":"4"}},{"id":1926994,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-04-04T20:07:38.000Z","date":"2023-03-06","kind":"grant","planned":false,"acquired":true,"shares":64655,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64655,"derivative":{"exercise_price":1.16,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":64655},"source":{"system":"sec-edgar","filing":"0001731122-23-000571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223000571/ownership.xml","form_type":"4"}},{"id":1942739,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-03-22T01:39:59.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":438597,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I."}],"balance_after":438597,"derivative":{"exercise_price":1.14,"exercise_date":"2023-03-17","expiration_date":"2028-03-17","underlying":"Common Stock","underlying_shares":438597},"source":{"system":"sec-edgar","filing":"0001731122-23-000444","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223000444/ownership.xml","form_type":"4"}},{"id":1942738,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":89467,"kind":"person","name":"Sindlev Rene","position":1,"cik":"0001709513","reported_name":"Sindlev Rene","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-03-22T01:39:59.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":877193,"price":1.14,"value":1000000.02,"ownership":{"direct":false,"nature":"By RS Bio ApS"},"balance_after":10545544,"source":{"system":"sec-edgar","filing":"0001731122-23-000444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223000444/ownership.xml","form_type":"4"}},{"id":2030305,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2022-10-13","kind":"other","acquired":true,"shares":1216467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."}],"balance_after":1313499,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030304,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2022-04-15","kind":"other","acquired":false,"shares":4961363,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pro rata distribution to the members of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pro rata distribution to the members of the Reporting Person."}],"balance_after":97032,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030303,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2022-04-11","kind":"other","acquired":true,"shares":97032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."}],"balance_after":5058395,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030302,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2020-12-14","kind":"other","acquired":true,"shares":61249,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."}],"balance_after":4961363,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030301,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2020-05-29","kind":"other","acquired":false,"shares":17545283,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pro rata distribution to the members of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pro rata distribution to the members of the Reporting Person."}],"balance_after":4900114,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030300,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2019-07-30","kind":"other","acquired":true,"shares":3631234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."}],"balance_after":22445397,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030299,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":1268880,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement."}],"balance_after":18814163,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030298,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":117222,"kind":"organization","name":"Weird Science LLC","position":1,"cik":"0001955760","reported_name":"Weird Science LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T00:24:58.000Z","date":"2018-02-16","kind":"other","acquired":true,"shares":17545283,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person received these shares as merger consideration in exchange for the Reporting Person's common stock of Enochian BioPharma, Inc., which the Issuer acquired by merger on February 16, 2018. In addition to such shares, the Agreement and Plan of Merger governing the merger (the \"Merger Agreement\") provides that upon the exercise or conversion of options and warrants to purchase shares of the Issuer's common stock that were outstanding as of the closing of the merger, the Issuer will issue a like number of shares of Common Stock (referred to as \"Earn-Out Stock\") to the former stockholders of Enochian BioPharma, Inc., including the Reporting Person, on a pro rata basis. The Reporting Person's right to receive additional shares of the Issuer's common stock as Earn-Out Stock became fixed and irrevocable on February 16, 2018, the closing date of the merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received these shares as merger consideration in exchange for the Reporting Person's common stock of Enochian BioPharma, Inc., which the Issuer acquired by merger on February 16, 2018. In addition to such shares, the Agreement and Plan of Merger governing the merger (the \"Merger Agreement\") provides that upon the exercise or conversion of options and warrants to purchase shares of the Issuer's common stock that were outstanding as of the closing of the merger, the Issuer will issue a like number of shares of Common Stock (referred to as \"Earn-Out Stock\") to the former stockholders of Enochian BioPharma, Inc., including the Reporting Person, on a pro rata basis. The Reporting Person's right to receive additional shares of the Issuer's common stock as Earn-Out Stock became fixed and irrevocable on February 16, 2018, the closing date of the merger."}],"balance_after":17545283,"source":{"system":"sec-edgar","filing":"0001214659-23-001671","document":"marketforms-58228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527728/000121465923001671/marketforms-58228.xml","form_type":"4"}},{"id":2030666,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-06T19:31:02.000Z","date":"2022-10-13","kind":"other","acquired":true,"shares":1216467,"ownership":{"direct":false,"nature":"Weird Science LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the \"Merger Agreement\") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were received as Earnout Stock pursuant to the Agreement and Plan of Merger dated January 12, 2018 (the \"Merger Agreement\") by and among the Issuer, its merger sub, Enochian Biopharma Inc. and Weird Science LLC. Weird Science's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the effective date of the closing under the Merger Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a manager of Weird Science LLC."}],"balance_after":1313499,"source":{"system":"sec-edgar","filing":"0001214659-23-001677","document":"marketforms-58231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465923001677/marketforms-58231.xml","form_type":"4"}},{"id":2030665,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-06T19:30:42.000Z","date":"2022-01-12","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2623484,"source":{"system":"sec-edgar","filing":"0001214659-23-001676","document":"marketforms-58235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465923001676/marketforms-58235.xml","form_type":"5"}},{"id":2030664,"issuer":{"id":7981,"kind":"organization","name":"Lunai Bioworks Inc."},"owners":[{"id":82066,"kind":"person","name":"William Anderson Wittekind","position":1,"cik":"0001753085","reported_name":"William Anderson Wittekind","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-06T19:30:42.000Z","date":"2021-12-14","kind":"gift","acquired":false,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2627484,"source":{"system":"sec-edgar","filing":"0001214659-23-001676","document":"marketforms-58235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1753085/000121465923001676/marketforms-58235.xml","form_type":"5"}}],"next_cursor":"2023-02-06T19:30:42.000000Z,2030664"}